Skip to main content
DNA Labs India

Hains Mycobacterium Tuberculosis First Line Drug Resistance Profile Test

DNA Labs India | ISO 9001:2015 Certified

Hains Mycobacterium Tuberculosis First Line Drug Resistance Profile Test

Short Name: HAINS MTB First Line Drug Resistance Profile

Also known as: HAINS Mycobacterium Tuberculosis Drug Resistance Test, HAINS MTB Drug Resistance Profile

Hains Mycobacterium Tuberculosis First Line Drug Resistance Profile Test test available at DNA Labs India for ₹3,000. Uses PCR, Line probe assay on Sputum / Bronchoalveolar Lavage / Pleural aspirates / CSF / Body fluid OR Cultured growth on appropriate media samples. Results in Sample collection: Tue / Fri by 11 am; Report available: Thu / Mon. Free home collection in 300+ cities across India.

Molecular Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

To diagnose drug-resistant tuberculosis by detecting mutations in genes responsible for resistance to Rifampicin and Isoniazid, first-line TB drugs.

Test Code
681
Price
₹3,000
Sample Type
Sputum / Bronchoalveolar Lavage / Pleural aspirates / CSF / Body fluid OR Cultured growth on appropriate media
Result Time
Sample collection: Tue / Fri by 11 am; Report available: Thu / Mon
Fasting Required
No
Method
PCR, Line probe assay
Step 1

Sample Collection

No special preparation required. Ensure sample is collected as per instructions.

Method: Physician-assisted or home collection

Step 2

Laboratory Analysis

Sample collected by healthcare professional; for sputum, deep cough into sterile container; other fluids via standard procedures.

Step 3

Report Delivery

Seal container properly and ship refrigerated; do not freeze.

Timeline: Sample collection: Tue / Fri by 11 am; Report available: Thu / Mon

Patient Instructions

1
Before the Test:No special preparation required. Inform your doctor about any medications or prior TB treatment.
2
During the Test:Sample collection is minimally invasive; for sputum, you may be asked to cough deeply; other samples collected via standard medical procedures.
3
After the Test:After sample collection, resume normal activities. Results will be delivered via your chosen method.

About This Test

Who Should Get This Test

To diagnose drug-resistant tuberculosis by detecting mutations in genes responsible for resistance to Rifampicin and Isoniazid, first-line TB drugs.

How to Prepare

  • Submit 2 mL (minimum 1 mL) of sputum, bronchoalveolar lavage, pleural aspirates, CSF, or body fluid
  • Alternatively, submit cultured growth on appropriate media in a sterile screw capped container
  • Place container in a sealed plastic bag
  • Ship refrigerated; do not freeze
  • Use provided home collection service if available

Doctor's Notes

Reviewed by — MBBS, MD (Microbiology) · Reg. No. 27670

"This test is critical for identifying drug-resistant TB strains, enabling targeted therapy and preventing transmission of resistant infections. Consult an infectious disease specialist for result interpretation and treatment planning."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeSputum / Bronchoalveolar Lavage / Pleural aspirates / CSF / Body fluid OR Cultured growth on appropriate media
Sample Volume2 mL (1 mL min.)
ContainerSterile screw capped container in a sealed plastic bag
Collection MethodPhysician-assisted or home collection

Sample Stability

Room Temperature
Refrigerator
Frozen
Sample Rejection Criteria:
  • Insufficient sample volume
  • Improperly labeled or contaminated sample
  • Sample not shipped refrigerated as instructed
  • Frozen sample

Understanding Your Results

Results indicate the presence or absence of mutations in genes associated with drug resistance to Rifampicin and Isoniazid.
📊

Mutation Detected

Strain is resistant to the respective drug; consider alternative treatment

📊

No Mutation Detected

Strain is likely susceptible to the drug, but clinical correlation is recommended

📊

Indeterminate

Repeat test or use additional diagnostics for confirmation

⚠️ When to Consult a Doctor:

Consult an infectious disease specialist or pulmonologist immediately after receiving results, especially if resistance is detected, to adjust treatment regimen and prevent complications.

Limitations

  • May not detect all genetic mutations causing resistance
  • Positive result confirms resistance but negative result does not entirely rule out resistance
  • Test performance depends on sample quality and bacterial load
  • Not a substitute for clinical evaluation and culture testing

Risks & Considerations

  • Minimal risk from sample collection, such as discomfort during sputum expectoration or fluid aspiration
  • No significant risks associated with the test itself

Interfering Factors

  • Sample contamination
  • Improper storage or shipping conditions
  • Low bacterial load in sample
  • Prior antibiotic treatment affecting bacterial presence

Compare With Similar Tests

TestHains Mycobacterium Tuberculosis First Line Drug Resistance Profile TestGeneXpert MTB/RIF TestSputum Culture and SensitivityTuberculin Skin TestChest X-ray
ComparisonHains Mycobacterium Tuberculosis First Line Drug Resistance Profile Test

Frequently Asked Questions

What is the HAINS MTB First Line Drug Resistance Profile Test?
It is a molecular test that detects mutations in genes associated with resistance to Rifampicin and Isoniazid, first-line drugs for tuberculosis.
Why is this test important?
It helps identify drug-resistant TB strains, enabling targeted treatment and preventing the spread of resistant infections.
What samples are required for the test?
Sputum, bronchoalveolar lavage, pleural aspirates, CSF, body fluid, or cultured growth on appropriate media.
How is the test performed?
The test uses PCR and line probe assay technology to analyze the sample for specific genetic mutations.
Is any preparation needed before the test?
No special preparation is required. Follow sample collection instructions provided.
How long does it take to get results?
Results are typically available on Thu / Mon for samples collected Tue / Fri by 11 am.
What does a positive result mean?
A positive result indicates the presence of mutations conferring resistance to Rifampicin or Isoniazid, requiring alternative treatment.
What does a negative result mean?
A negative result suggests no detected mutations, indicating likely susceptibility, but clinical correlation is advised.
Are there any risks associated with the test?
Risks are minimal, primarily related to sample collection discomfort; the test itself has no significant risks.
Is home sample collection available?
Yes, free home collection is offered for online bookings in numerous cities across India.
How much does the test cost?
The test costs INR 3000, with discounts available for online bookings.
What should I do after getting the results?
Consult an infectious disease specialist or pulmonologist immediately, especially if resistance is detected, to plan treatment.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.